Media and Investors Resources

Press Release, 26 October 2021

Adhoc Press Release

Kuros Biosciences reports continued increase in MagnetOs U.S. sales

Press Release, 28 September 2021

Kuros Biosciences to showcase new MagnetOs products at NASS 2021 Annual Meeting

Press Release, 9 September 2021

Kuros Biosciences Announces FDA 510(k) Clearance for MagnetOs Easypack Putty

Press Release, 11 August 2021

Adhoc Press Release

Kuros Biosciences Reports Results for First Half 2021

Kuros Interim Results, 2021

English version

Press Release, 15 July 2021

Adhoc Press Release

Kuros to receive $7 million up front and potentially $166.5 million in future revenues under a royalty purchase agreement with XOMA related to Kuros’s license agreement with Checkmate Pharmaceuticals